机译:新型的抑制蛋白质合成的多阶段抗疟药
Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Drug Discovery Unit, Dundee DD1 5EH, Scotland;
Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Drug Discovery Unit, Dundee DD1 5EH, Scotland;
Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA;
Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Drug Discovery Unit, Dundee DD1 5EH, Scotland;
Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Drug Discovery Unit, Dundee DD1 5EH, Scotland;
Wellcome Trust Sanger Inst, Malaria Programme, Cambridge CB10 1SA, England;
Charles Darwin Univ, Menzies Sch Hlth Res, Global Hlth & Trop Med Div, Darwin, NT 0811, Australia;
Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England;
Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA;
Charles Darwin Univ, Menzies Sch Hlth Res, Global Hlth & Trop Med Div, Darwin, NT 0811, Australia;
Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England;
Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England;
Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA;
Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA;
Univ S Florida, Coll Publ Hlth, Dept Global Hlth, Tampa, FL 33612 USA;
Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Drug Discovery Unit, Dundee DD1 5EH, Scotland;
GlaxoSmithKline, Madrid 28760, Spain;
TropIQ Hlth Sci, NL-6525 GA Nijmegen, Netherlands;
Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Drug Discovery Unit, Dundee DD1 5EH, Scotland;
Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Drug Discovery Unit, Dundee DD1 5EH, Scotland;
Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Drug Discovery Unit, Dundee DD1 5EH, Scotland;
Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Drug Discovery Unit, Dundee DD1 5EH, Scotland;
Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Drug Discovery Unit, Dundee DD1 5EH, Scotland;
Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Drug Discovery Unit, Dundee DD1 5EH, Scotland;
Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Drug Discovery Unit, Dundee DD1 5EH, Scotland;
Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England;
Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England;
Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England;
Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England;
GlaxoSmithKline, Madrid 28760, Spain;
GlaxoSmithKline, Madrid 28760, Spain;
Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Drug Discovery Unit, Dundee DD1 5EH, Scotland;
Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA;
Monash Univ, Ctr Drug Candidate Optimisat, Parkville, Vic 3052, Australia;
Griffith Univ, Eskitis Inst, Nathan, Qld 4111, Australia;
TropIQ Hlth Sci, NL-6525 GA Nijmegen, Netherlands;
TropIQ Hlth Sci, NL-6525 GA Nijmegen, Netherlands;
Eijkman Inst Mol Biol, Malaria Pathogenesis Lab, Jakarta 10430, Indonesia;
Med Malaria Venture, CH-1215 Geneva 15, Switzerland;
Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Drug Discovery Unit, Dundee DD1 5EH, Scotland;
GlaxoSmithKline, Madrid 28760, Spain;
GlaxoSmithKline, Madrid 28760, Spain;
GlaxoSmithKline, Madrid 28760, Spain;
Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Drug Discovery Unit, Dundee DD1 5EH, Scotland;
Med Malaria Venture, CH-1215 Geneva 15, Switzerland;
Med Malaria Venture, CH-1215 Geneva 15, Switzerland;
Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England;
Univ S Florida, Coll Publ Hlth, Dept Global Hlth, Tampa, FL 33612 USA;
Swiss Trop & Publ Hlth Inst, CH-4051 Basel, Switzerland;
Charles Darwin Univ, Menzies Sch Hlth Res, Global Hlth & Trop Med Div, Darwin, NT 0811, Australia;
Charles Darwin Univ, Menzies Sch Hlth Res, Global Hlth & Trop Med Div, Darwin, NT 0811, Australia|Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford OX3 7LJ, England;
Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England;
Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA;
Monash Univ, Ctr Drug Candidate Optimisat, Parkville, Vic 3052, Australia;
Med Malaria Venture, CH-1215 Geneva 15, Switzerland;
Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Drug Discovery Unit, Dundee DD1 5EH, Scotland;
Med Malaria Venture, CH-1215 Geneva 15, Switzerland;
Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Drug Discovery Unit, Dundee DD1 5EH, Scotland;
Med Malaria Venture, CH-1215 Geneva 15, Switzerland;
Wellcome Trust Sanger Inst, Malaria Programme, Cambridge CB10 1SA, England;
Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA|Columbia Univ Coll Phys & Surg, Dept Med, Div Infect Dis, New York, NY 10032 USA;
Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Drug Discovery Unit, Dundee DD1 5EH, Scotland;
Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Drug Discovery Unit, Dundee DD1 5EH, Scotland;
机译:抑制蛋白质合成的新型多阶段抗疟药(第522卷,第315页,2015年)
机译:新的潜在抗疟药:一些新颖的喹啉衍生物作为抗疟药的设计,合成和生物学评估
机译:新的潜在抗疟药:一些新颖的喹啉衍生物作为抗疟药的设计,合成和生物学评估
机译:通过基于结构的虚拟筛选鉴定新型Falcipain-2抑制剂作为潜在的抗疟药
机译:黄酮类化合物作为脲酶抑制剂和抗疟剂的利用以及细菌蛋氨酸氨基肽酶抑制剂的发现。
机译:新型的抑制蛋白质合成的多阶段抗疟药
机译:更正:抑制蛋白质合成的新型多阶段抗疟药。
机译:脂肪氧化产物与其他食品成分,抗氧化剂和诱捕剂抑制蛋白质交联的研究